Medicsen is a startup working on a non-invasive artificial pancreas for people with diabetes. This device is capable of predicting future glucose values in the patient with a one-hour advance notice and a margin of error of fewer than 10 glucose units, while also providing practical lifestyle advice for disease management.
Problem
Traditional diabetes management often involves invasive methods like constant blood glucose monitoring and injections, which can be uncomfortable and disruptive to patients' lives. Medicsen's innovation seeks to offer a device that predicts future glucose levels accurately, allowing patients to manage their condition proactively. This approach reduces the need for invasive procedures, enhances patients' quality of life, and provides practical lifestyle guidance for better disease management.
